Page 28 - Read Online

Verriello et al. Vessel Plus 2021;5:51 https://dx.doi.org/10.20517/2574-1209.2021.69 Page 11 of 11

2003;10:185-9. DOI PubMed
31. Riboldi G, Del Bo R, Ranieri M, et al. Tyr78Phe Transthyretin Mutation with Predominant Motor Neuropathy as the Initial
Presentation. Case Rep Neurol 2011;3:62-8. DOI PubMed PMC
32. Lozeron P, Lacroix C, Theaudin M, et al. An amyotrophic lateral sclerosis-like syndrome revealing an amyloid polyneuropathy
associated with a novel transthyretin mutation. Amyloid 2013;20:188-92. DOI PubMed
33. Eldhagen P, Berg S, Lund LH, Sörensson P, Suhr OB, Westermark P. Transthyretin amyloid deposits in lumbar spinal stenosis and
assessment of signs of systemic amyloidosis. J Intern Med 2021;289:895-905. DOI PubMed PMC
34. Guy CD, Jones CK. Abdominal fat pad aspiration biopsy for tissue confirmation of systemic amyloidosis: specificity, positive
predictive value, and diagnostic pitfalls. Diagn Cytopathol 2001;24:181-5. DOI PubMed
35. Adams D, Suhr OB, Hund E, et al; European Network for TTR-FAP (ATTReuNET). First European consensus for diagnosis,
management, and treatment of transthyretin familial amyloid polyneuropathy. Curr Opin Neurol 2016;29 Suppl 1:S14-26. DOI
PubMed PMC
36. Cowan AJ, Skinner M, Berk JL, et al. Macroglossia - not always AL amyloidosis. Amyloid 2011;18:83-6. DOI PubMed
37. Briani C, Cavallaro T, Ferrari S, et al. Sporadic transthyretin amyloidosis with a novel TTR gene mutation misdiagnosed as primary
amyloidosis. J Neurol 2012;259:2226-8. DOI PubMed
38. Conceição I, González-Duarte A, Obici L, et al. "Red-flag" symptom clusters in transthyretin familial amyloid polyneuropathy. J
Peripher Nerv Syst 2016;21:5-9. DOI PubMed PMC
39. Coutinho P, Martins da Silva A, Lopas LJ. Forty years of experience with type 1 amyloid neuropathy. Review of 483 cases. In:
Amyloid and amyloidosis. Amsterdam: Excerpta Medica;1980. p. 88-98.
40. Sletten DM, Suarez GA, Low PA, Mandrekar J, Singer W. COMPASS 31: a refined and abbreviated Composite Autonomic Symptom
Score. Mayo Clin Proc 2012;87:1196-201. DOI PubMed PMC
41. Joy T, Wang J, Hahn A, Hegele RA. Apoa1 related amyloidosis: a case report and literature review. Clin Biochem 2003;36:641-5.
DOI PubMed
42. Kiuru S, Seppäläinen AM. Neuropathy in familial amyloidosis , Finnish type (FAF): electrophysiological studies. Muscle Nerve
1994;17:299-304. DOI PubMed
43. Boysen G, Galassi G, Kamieniecka Z, Schlaeger J, Trojaborg W. Familial amyloidosis with cranial neuropathy and corneal lattice
dystrophy. J Neurol Neurosurg Psychiatry 1979;42:1020-30. DOI PubMed PMC
44. Sunada Y, Shimizu T, Nakase H, et al. Inherited amyloid polyneuropathy type IV (gelsolin variant) in a Japanese family. Ann Neurol
1993;33:57-62. DOI PubMed
45. Kyle RA, Larson DR, Kurtin PJ, et al. Incidence of AL Amyloidosis in Olmsted county, Minnesota, 1990 through 2015. Mayo Clin
Proc 2019;94:465-71. DOI PubMed PMC
46. Zampieri M, Cappelli F, Allinovi M, et al. Incidence of light chain amyloidosis in Florence metropolitan area, Italy: a population-based
study. Amyloid 2021;28:211-2. DOI PubMed
47. Obici L, Perfetti V, Palladini G, Moratti R, Merlini G. Clinical aspects of systemic amyloid diseases. Biochim Biophys Acta
2005;1753:11-22. DOI PubMed
48. Matsuda M, Gono T, Morita H, Katoh N, Kodaira M, Ikeda S. Peripheral nerve involvement in primary systemic AL amyloidosis: a
clinical and electrophysiological study. Eur J Neurol 2011;18:604-10. DOI PubMed
49. Kyle RA, Gertz MA. Primary systemic amyloidosis: clinical and laboratory features in 474 cases. Semin Hematol 1995;32):45-59.
PubMed
50. Vucic S, Chong PS, Cros D. Atypical presentations of primary amyloid neuropathy. Muscle Nerve 2003;28:696-702. DOI PubMed
51. Luigetti M, Papacci M, Bartoletti S, Marcaccio A, Romano A, Sabatelli M. AL amyloid neuropathy mimicking a chronic inflammatory
demyelinating polyneuropathy. Amyloid 2012;19:53-5. DOI PubMed
52. Adams D. Hereditary and acquired amyloid neuropathies. J Neurol 2001;248:647-57. DOI PubMed
53. Falk RH, Skinner M. The systemic amyloidosis: an overview. Adv Intern Med 2000. PubMed
54. Blank N, Hegenbart U, Dietrich S, et al. Obesity is a significant susceptibility factor for idiopathic AA amyloidosis. Amyloid
2018;25:37-45. DOI PubMed
55. Gaspar BL, Garg C, Vasishta RK, Nada R, Goyal MK. Localised SAA amyloidosis with intra-axonal intra-myelin amyloid deposits.
Pathology 2017;49:103-5. DOI PubMed
56. Maury CP. beta 2-Microglobulin amyloidosis. A systemic amyloid disease affecting primarily synovium and bone in long-term
dialysis patients. Rheumatol Int 1990;10:1-8. DOI PubMed
57. Valleix S, Gillmore JD, Bridoux F, et al. Hereditary systemic amyloidosis due to Asp76Asn variant β2-microglobulin. N Engl J Med
2012;366:2276-83. DOI PubMed